Sidney Baudendistel

Dr. Sidney Baudendistel

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in Gait & Posture
Verified
Journal Article
Closed access
SBSidney Baudendistel
Sidney Baudendistel
ASAbigail C. Schmitt
Abigail C. Schmitt
ASAmanda E. Stone
Amanda E. Stone
TRTiphanie E. Raffegeau
Tiphanie E. Raffegeau
JRJaimie A. Roper
Jaimie A. Roper
CHChris J. Hass
Chris J. Hass

1 June 2021 in Journal of Biomechanics
Verified
Journal Article
Closed access
NPNoah L. Pieper
Noah L. Pieper
SBSidney Baudendistel
Sidney Baudendistel
CHChris J. Hass
Chris J. Hass
GDGabriela B. Diaz
Gabriela B. Diaz
RKRebecca L. Krupenevich
Rebecca L. Krupenevich
Jason R. FranzJason R. Franz
Jason R. Franz

24 March 2021 in Journal of Biomechanics
Verified
Journal Article
Closed access
SBSidney Baudendistel
Sidney Baudendistel
ASAbigail C. Schmitt
Abigail C. Schmitt
RRRyan T. Roemmich
Ryan T. Roemmich
IHIsobel L. Harrison
Isobel L. Harrison
CHChris J. Hass
Chris J. Hass

30 April 2025 in Neurodegenerative Disease Management
Verified
Journal Article
Open access
SBSidney Baudendistel
Sidney Baudendistel
GEGammon M Earhart
Gammon M Earhart
The purpose of this review is to identify the characteristics of responders in interventions targeting motor function for individuals with Parkinson disease. The primary search included, 'Parkinson' + 'responder.' A second, broader, search further included 'response' + 'responsiveness' + 'responsive.' Records were sorted by intervention: neuromodulation, pharmaceutical, physical, and placebo. Thirteen studies were identified in the primary and 19 studies in the secondary search, culminating in 120 characteristics. For neuromodulation interventions, responders were younger at onset, more responsive to levodopa, and had more difficulties with activities of daily living. Responders to pharmaceuticals were younger at diagnosis. Physical intervention responders had worse balance, less balance confidence, and worse cognition. No relevant characteristics were identified for placebo interventions. Although there are clear limitations and gaps in the literature, responder analyses represent an important step toward more personalized treatments for the motor symptoms of Parkinson disease.

7 February 2020 in Parkinson's Disease
Verified
Journal Article
Open access
PDF file
ASAbigail C. Schmitt
Abigail C. Schmitt
SBSidney Baudendistel
Sidney Baudendistel
MFMichaela S. Fallon
Michaela S. Fallon
JRJaimie A. Roper
Jaimie A. Roper
CHChris J. Hass
Chris J. Hass
Gait impairment and increased gait variability are common among individuals with Parkinson’s disease (PD) and have been associated with increased risk for falls. The development of composite scores has gained interest to aggregate multiple aspects of gait into a single metric. The Enhanced Gait Variability Index (EGVI) was developed to compare an individual’s gait variability to the amount of variability in a healthy population, yet the EGVI’s individual parts may also provide important information that may be lost in this conversion. We sought to contrast individual gait measures as predictors of fall frequency and the EGVI as a single predictor of fall frequency in individuals with PD. 273 patients (189M, 84F; 68 ± 10 yrs) with idiopathic PD walked over an instrumented walkway and reported fall frequency over three months (never, rarely, monthly, weekly, or daily). The predictive ability of gait velocity, step length, step time, stance time, and single support time and the EGVI was assessed using regression techniques to predict fall frequency. The EGVI explained 15.1% of the variance in fall frequency (p<0.001, r = 0.389). Although the regression using the combined spatiotemporal measures to predict fall frequency was significant (p=0.002, r = 0.264), none of the components reached significance (gait velocity: p=0.640, step length: p=0.900, step time: p=0.525, stance time: p=0.532, single support time: p=0.480). The EGVI is a better predictor of fall frequency in persons with PD than its individual spatiotemporal components. Patients who fall more frequently have more variable gait, based on the interpretation of the EGVI. While the EGVI provides an objective measure of gait variability with some ability to predict fall frequency, full clinical interpretations and applications are currently unknown.

1 December 2019 in Clinical Biomechanics
Verified
Journal Article
Closed access
SBSidney Baudendistel
Sidney Baudendistel
ASAbigail C. Schmitt
Abigail C. Schmitt
ARAshley V. Rodriguez
Ashley V. Rodriguez
NMNikolaus R. McFarland
Nikolaus R. McFarland
CHChris J. Hass
Chris J. Hass